Enhancing Medication Adherence and Symptom Management in Benign Prostate Hyperplasia Patients: A Hospital-Based Intervention Study

Abstract

Objectives: Benign Prostate Hyperplasia (BPH) is a common condition affecting aging males, characterized by prostate enlargement and associated urinary symptoms. Despite available treatments, medication adherence remains a challenge, leading to suboptimal outcomes.Materials and Methods: This hospital-based study recruited 90 male BPH patients and assessed medication adherence using the Morisky Medication Adherence Scale (MMAS-8) and symptom severity using the International Prostate Symptom Score (IPSS). Statistical analysis compared baseline and follow-up data using appropriate tests.Results: Most patients were aged 51-80 years, with moderate symptoms at baseline shifting to mild symptoms at follow-up. Medication adherence significantly improved from baseline, with fewer non-adherent patients. Common symptoms included nocturia, frequency and urgency, with tamsulosin being the predominant medication.Conclusion: Pharmaceutical care interventions led to improved medication adherence and symptom management in BPH patients. The study underscores the importance of addressing medication adherence and symptom control in BPH management. Individualized treatment approaches and lifestyle modifications are crucial for optimizing outcomes. Further research should explore effective intervention components and long-term effects on disease progression, enhancing BPH patient quality of life.

Keywords: Benign Prostate Hyperplasia; Pharmacist interventional study; Medication Adherence